Argos Therapeutics, Inc. , a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis technology platform, today reported financial results for the first quarter ended March 31, 2014, and provided an update on the Company's ... (more)
http://ift.tt/1mSPg4L
http://ift.tt/1mSPg4L
No comments:
Post a Comment